MktsMarkets

Immunocore Holdings plc
NASDAQ: IMCRKey statistics
IMCR News
Stories mentioning IMCR from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 106,677 | 104,478 | 103,693 | 97,964 | 93,881 | 84,052 | 80,248 | 75,400 |
| Cost of Goods Sold | 434.00 | 2,703 | 513.00 | 1,040 | 831.00 | 330.00 | 448.00 | 1,707 |
| Gross Profit | 106,243 | 101,775 | 103,180 | 96,924 | 93,050 | 83,722 | 79,800 | 73,693 |
| Operating Expenses | ||||||||
| Research & Development | 61,113 | 78,821 | 70,572 | 69,008 | 56,468 | 60,850 | 52,770 | 51,072 |
| Sales General & Admin | 37,850 | 42,645 | 39,779 | 42,791 | 40,198 | 42,324 | 35,532 | 38,638 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | 7,280 | (19,691) | (7,171) | (14,875) | (3,616) | (19,452) | (8,502) | (16,017) |
| Interest Income | 3,418 | 3,906 | 4,123 | 4,271 | 4,176 | 5,173 | 5,960 | 6,239 |
| Interest Expense | ||||||||
| Other Expense | 1,776 | 4,504 | 5,062 | 4,693 | 5,469 | 993.00 | 8,962 | 4,433 |
| Pretax Income | 13,272 | (15,794) | 304.00 | (9,694) | 6,084 | (24,821) | 6,093 | (10,130) |
| Tax Provision | 301.00 | 14,266 | 481.00 | 606.00 | 1,061 | (1,050) | (2,643) | 1,486 |
| Net Income (Loss) | 12,971 | (30,060) | (177.00) | (10,300) | 5,023 | (23,771) | 8,736 | (11,616) |
| Earnings Per Share (Basic) | 0.26 | (0.60) | 0.00 | (0.20) | 0.10 | (0.48) | 0.17 | (0.23) |
| Earnings Per Share (Diluted) | 0.25 | (0.60) | 0.00 | (0.20) | 0.10 | (0.48) | 0.17 | (0.23) |
| Weighted Average Shares Outstanding (Basic) | 50,755 | 50,346 | 50,404 | 50,294 | 50,087 | 49,991 | 50,022 | 50,014 |
| Weighted Average Shares Outstanding (Diluted) | 52,935 | 50,346 | 50,404 | 50,294 | 51,950 | 49,991 | 52,808 | 50,014 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About IMCR
Immunocore Holdings plc (NASDAQ: IMCR) is a stock listed on the Nasdaq Stock Market under the ticker symbol IMCR. It last traded at $26.41 (Nov 20, 2026, 4:00 PM ET), down 0.8% on the day. That gives Immunocore a market capitalisation of $1.4B.
Over the past 52 weeks IMCR has traded between $27.31 and $40.71.
Revenue for the quarter ended Mar 31, 2026 was $106.7M; net income $13.0M. Revenue was up 13.6% from $93.9M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $106.7M | $13.0M | 12.2% |
| Dec 31, 2025 | $104.5M | -$30.1M | -28.8% |
| Sep 30, 2025 | $103.7M | -$177.0K | -0.2% |
| Jun 30, 2025 | $98.0M | -$10.3M | -10.5% |
From Immunocore’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…